 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
 |
 |
 |
Phase: |
 |
Phase 3 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1750 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Not Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
09/22/2012 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
Newly diagnosed only. |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Surgery Chemotherapy Radiation Immunological, Biological or Targeted Therapy |
 |
 |
 |
 |
Contact: |
 |
David M. Peereboom MD Head, Clinical Research and Medical Oncology Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center
Cleveland, OH 44195 USA Phone: 216-445-6068 Fax: 216-444-9464 E-mail: peerebd@ccf.org Website: my.clevelandclinic.org/brain_tumor/default.aspx |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|